Is Centessa Pharmaceuticals plc (CNTA) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 3.1% / 30% | 12.6% / 30% | 1.2% / 30% | N/A | ✓ HALAL |
| DJIM | 3.1% / 33% | 12.6% / 33% | 1.2% / 33% | N/A | ✓ HALAL |
| MSCI | 20.3% / 33% | 83.6% / 33% | 7.9% / 33% | N/A | ✗ NOT HALAL |
| S&P | 3.1% / 33% | 12.6% / 33% | 1.2% / 33% | N/A | ✓ HALAL |
| FTSE | 20.3% / 33% | 83.6% / 33% | 7.9% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 100.0% | |
| Operating Margin | -1425.3% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -60.6% | |
| Return on Assets (ROA) | -25.3% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$142M |
| Free Cash Flow | -$142M |
| Total Debt | $117M |
| Debt-to-Equity | 39.2 |
| Current Ratio | 10.6 |
| Total Assets | $577M |
Price & Trading
| Last Close | $29.40 |
| 50-Day MA | $25.80 |
| 200-Day MA | $22.09 |
| Avg Volume | 1.3M |
| Beta | 1.6 |
|
52-Week Range
$9.60
| |
About Centessa Pharmaceuticals plc (CNTA)
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines. Its lead clinical-stage program includes ORX750, an orally administered OX2R agonist in a Phase 2a study for the treatment of idiopathic hypersomnia and narcolepsy type 1 and 2. The company also develops ORX142 for the treatment of neurological and neurodegenerative disorders, as well as other potential symptoms, including excessive daytime sleepiness, impaired attention, cognitive deficits, and fatigue; and ORX489 for the treatment of neuropsychiatric disorders. In addition, it offers LockBody, which is designed to selectively drive potent effector function activity, such as CD3, into the tumor microenvironment. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Centessa Pharmaceuticals plc (CNTA) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Centessa Pharmaceuticals plc is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Centessa Pharmaceuticals plc's debt ratio?
Centessa Pharmaceuticals plc's debt ratio is 3.1% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 20.3%.
What are Centessa Pharmaceuticals plc's key financial metrics?
Centessa Pharmaceuticals plc has a market capitalization of $4.2B. Return on equity stands at -60.6%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.